Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Showing results (131-140 of 945) with videos related to

Pageof 95
Sort By:
Diagnostic Microbiology and Infectious Disease|May 1, 1997
Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: analysis of the correlations between in vitro test results and clinical responseR N Jones, M N Dudley
Diagnostic Microbiology and Infectious Disease|May 1, 1989
In vitro evaluation of ramoplanin (A16686 or MDL62198). A new depsipeptide complex for potential topical useR N Jones, A L Barry
The Journal of Antimicrobial Chemotherapy|December 1, 1989
A simple stacked disc technique for testing bacterial susceptibility to antimicrobial agents in combination with sulbactamA L Barry, R N Jones
Journal of Clinical Microbiology|January 1, 1988
Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combinationA L Barry, R N Jones
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|October 1, 1988
In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporinR N Jones, A L Barry
Journal of Clinical Microbiology|December 1, 1996
Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug AdministrationD J Biedenbach, R N Jones
Diagnostic Microbiology and Infectious Disease|July 13, 2001
Validation of cefditoren MIC quality control ranges by a multi-laboratory study (2001)R N Jones, D J Biedenbach,
Journal of Clinical Microbiology|August 1, 1987
Cross susceptibility and absence of cross resistance to cefotetan and cefoxitinA L Barry, R N Jones
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
Ceftibuten (7432-S, SCH 39720): comparative antimicrobial activity against 4735 clinical isolates, beta-lactamase stability and broth microdilution quality control guidelinesR N Jones, A L Barry
Journal of Clinical Microbiology|October 1, 1987
Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combinationR N Jones, A L Barry
Pageof 95

Showing results (131-140 of 945) with videos related to

Sort By:
Pageof 95
Diagnostic Microbiology and Infectious Disease|May 1, 1997
Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: analysis of the correlations between in vitro test results and clinical responseR N Jones, M N Dudley
Diagnostic Microbiology and Infectious Disease|May 1, 1989
In vitro evaluation of ramoplanin (A16686 or MDL62198). A new depsipeptide complex for potential topical useR N Jones, A L Barry
The Journal of Antimicrobial Chemotherapy|December 1, 1989
A simple stacked disc technique for testing bacterial susceptibility to antimicrobial agents in combination with sulbactamA L Barry, R N Jones
Journal of Clinical Microbiology|January 1, 1988
Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combinationA L Barry, R N Jones
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|October 1, 1988
In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporinR N Jones, A L Barry
Journal of Clinical Microbiology|December 1, 1996
Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug AdministrationD J Biedenbach, R N Jones
Diagnostic Microbiology and Infectious Disease|July 13, 2001
Validation of cefditoren MIC quality control ranges by a multi-laboratory study (2001)R N Jones, D J Biedenbach,
Journal of Clinical Microbiology|August 1, 1987
Cross susceptibility and absence of cross resistance to cefotetan and cefoxitinA L Barry, R N Jones
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
Ceftibuten (7432-S, SCH 39720): comparative antimicrobial activity against 4735 clinical isolates, beta-lactamase stability and broth microdilution quality control guidelinesR N Jones, A L Barry
Journal of Clinical Microbiology|October 1, 1987
Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combinationR N Jones, A L Barry
Pageof 95